Skip To Main Content
Zhenying Zuo on Muck Rack

Zhenying Zuo

As seen in: Nature, Dove Medical Press
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Zhenying

Contact Zhenying, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Docosahexaenoic acid attenuates cisplatin nephrotoxicity by restoring mitophagy

|
By Zhenying Zuo, Chen Yang, Shangmei Li, Huafeng Liu, Yuxian Zhuang, Kaipeng Jing
| Nature Verified
Abstract Cisplatin exhibits potent antitumor efficacy but also causes dose-dependent nephrotoxicity mediated through apoptosis of renal tubular epithelial cells, which limits its clinical application. Cisplatin induces significant mitophagy in these cells; however, the mechanisms underlying its effects on apoptotic processes remain incompletely elucidated.
Open in Who Shared Issue with article?

Inhibitor of KAT2A alleviate the progression of AKI by alleviating mac

|
By Shenglan Gao, Jinzheng Wang, Zhongyu Liu, Zhenying Zuo
| Dove Medical Press
Back to Journals » ImmunoTargets and Therapy » Volume 14 Authors Zuo Z, Gao S, Wang J, Liu Z, Lu Z, Wu H, Hang X, Yang C , Chen J, Liu H, Pan Q, Yang L Received 10 October 2025 Accepted for publication 16 December 2025 Published 28 December 2025 Volume 2025:14 Pages 1515—1529 DOI https://doi.org/10.2147/ITT.S568586 Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 2 Editor who approved publication: Professor Michael Shurin Zhenying Zuo,* Shenglan...
Open in Who Shared Issue with article?
See all 2 articles